FDA Approves Vafseo Tablets to Treat Anemia in Chronic Kidney Disease Patients
TPMG is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Akebia pharmaceutical’s Vafseo® (vadadustat) tablets, a drug used for the treatment of anemia from chronic kidney disease (CKD) in adults on dialysis.












